ÂÜÀòÂÒÂ×

Prior to his Hopkins appointment, Dr. Levy was medical director of Thoracic Oncology Program for Mount Sinai Health Systems in New York City and associate director of the Cancer Clinical Trials Office (CCTO).

Dr. Levy is a physician-scientist who is currently leading immunotherapy trials evaluating checkpoint inhibitors with novel combination strategies, as well as targeted therapy trials. Dr. Levy has played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee as well as editor-in-chief for the ASCO Self-Evaluation Program (ASCO-SEP®).

He recently completed two terms on the editorial board for the Journal of Clinical Oncology (JCO) and currently serves as senior associate editor for Clinical Lung Cancer. He is an ad hoc reviewer for The Oncologist, Oncotarget, and Clinical Cancer Research (CCR).